Inventor · disambiguated record
Garrett Michael Frampton
Also filed as: FRAMPTON GARRETT · FRAMPTON GARRETT M · FRAMPTON GARRETT MICHAEL
12 granted patents·16 pending applications·33 citations·filing 2013–2025
89Inventor score
Top patents by PatentIndex Score
28 records- 0193US9907798B2Methods of treating head and neck cancerFOUND MEDICINE INC·Filed 2016·Granted Mar 6, 2018·7 cites·22 claims
- 0291US11279767B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2018·Granted Mar 22, 2022·7 cites·11 claims
- 0391US9410954B2Human papilloma virus as predictor of cancer prognosisFOUND MEDICINE INC·Filed 2014·Granted Aug 9, 2016·8 cites·25 claims
- 0490US11300570B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2019·Granted Apr 12, 2022·3 cites·18 claims
- 0590US2025146077A1Novel estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2024·Application pending·0 cites
- 0688US8673972B2Human papilloma virus as predictor of cancer prognosisFOUNDATION MEDICINE INC·Filed 2013·Granted Mar 18, 2014·5 cites·20 claims
- 0786US11286532B2Estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2018·Granted Mar 29, 2022·1 cites·15 claims
- 0885US11058687B2Human papilloma virus as predictor of cancer prognosisFOUND MEDICINE INC·Filed 2019·Granted Jul 13, 2021·1 cites·49 claims
- 0981US12116638B2Estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2022·Granted Oct 15, 2024·0 cites·25 claims
- 1079US10093983B2Estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2015·Granted Oct 9, 2018·1 cites·26 claims
- 1176US11766439B2Human papilloma virus as predictor of cancer prognosisFOUND MEDICINE INC·Filed 2021·Granted Sep 26, 2023·0 cites·18 claims
- 1276US2025306027A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2025·Application pending·0 cites
- 1374US2022412981A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 1474US2025191683A1Methods and systems for characterizing and treating a diseaseFOUND MEDICINE INC·Filed 2024·Application pending·0 cites
- 1573US2019233897A1Novel estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2018·Application pending·0 cites
- 1671US12331128B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Granted Jun 17, 2025·0 cites·13 claims
- 1770US2025125008A1Methods and systems for evaluation of sex biases in identifying molecular biomarkers for diseaseFOUND MEDICINE INC·Filed 2024·Application pending·0 cites
- 1870US2014221329A1Novel estrogen receptor mutations and uses thereofFOUNDATION MEDICINE INC·Filed 2014·Application pending·0 cites
- 1968US2018338977A1Human papilloma virus as predictor of cancer prognosisFOUND MEDICINE INC·Filed 2018·Application pending·0 cites
- 2066US2017016073A1Novel estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2016·Application pending·0 cites
- 2164US2024392378A1Methods of treating cancerFOUND MEDICINE INC·Filed 2023·Application pending·0 cites
- 2264US2016201135A1Novel estrogen receptor mutations and uses thereofTEVA PHARMA·Filed 2015·Application pending·0 cites
- 2363US2025201421A1Methods and systems for normalizing targeted sequencing dataFOUND MEDICINE INC·Filed 2024·Application pending·0 cites
- 2463US2025210194A1Methods and systems for determining tumor heterogeneityFOUND MEDICINE INC·Filed 2023·Application pending·0 cites
- 2559US2025014678A1Methods and systems for reporting clinically-actionable potential germline pathogenic variant sequencesFOUND MEDICINE INC·Filed 2021·Application pending·0 cites
- 2656US2025272835A1Predicting treatment efficacy by analyzing non-cancer cellsFOUND MEDICINE INC·Filed 2025·Application pending·0 cites
- 2753US11725247B2Methods of treating cancerFOUND MEDICINE INC·Filed 2017·Granted Aug 15, 2023·0 cites·16 claims
- 2846US2018363066A1Methods and systems for evaluating tumor mutational burdenFOUND MEDICINE INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Garrett Michael Frampton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →